Malam - Team Ltd (TLV:MLTM)

SpringWorks Therapeutics Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,520	1,734	1,073	1,638	2,485	1,971
Market Cap Growth	11.67%	61.65%	-34.52%	-34.07%	26.11%	37.32%
Enterprise Value	3,138	2,347	1,863	2,356	2,740	2,259
Last Close Price	115.10	79.21	49.00	73.07	107.48	82.31
PE Ratio	25.94	19.59	16.79	29.23	36.66	25.97
PS Ratio	0.66	0.46	0.35	0.61	1.10	0.88
PB Ratio	3.43	2.47	1.75	2.81	4.31	3.28
P/TBV Ratio	10.50	8.19	7.71	11.14	13.59	9.09
P/FCF Ratio	19.93	7.16	5.32	-	14.49	6.66
P/OCF Ratio	18.08	6.89	4.86	41.98	11.85	6.32
EV/Sales Ratio	0.82	0.62	0.62	0.87	1.21	1.01
EV/EBITDA Ratio	9.92	9.14	8.91	13.07	15.43	13.27
EV/EBIT Ratio	15.20	11.59	12.74	20.55	22.89	17.61
EV/FCF Ratio	24.83	9.69	9.23	-	15.98	7.64
Debt / Equity Ratio	1.30	1.34	1.59	1.62	0.84	0.74
Debt / EBITDA Ratio	2.97	2.99	3.67	3.91	2.01	1.90
Debt / FCF Ratio	7.54	3.88	4.83	-	2.83	1.49
Asset Turnover	1.52	1.57	1.34	1.40	1.36	1.45
Inventory Turnover	52.53	54.73	35.26	45.01	70.63	65.22
Quick Ratio	1.17	1.11	1.12	0.90	1.12	1.15
Current Ratio	1.22	1.27	1.32	1.08	1.26	1.25
Return on Equity (ROE)	14.81%	14.07%	10.73%	9.63%	11.47%	13.37%
Return on Assets (ROA)	5.26%	5.26%	4.04%	3.72%	4.47%	5.19%
Return on Capital (ROIC)	7.92%	7.84%	5.87%	5.54%	7.11%	8.12%
Return on Capital Employed (ROCE)	16.30%	15.30%	10.90%	10.60%	13.60%	15.10%
Earnings Yield	3.86%	5.10%	5.95%	3.42%	2.73%	3.85%
FCF Yield	5.02%	13.96%	18.81%	-2.91%	6.90%	15.01%
Dividend Yield	-	-	2.04%	3.42%	2.33%	3.04%
Payout Ratio	-	-	51.41%	136.92%	113.05%	28.86%
Total Shareholder Return	-	-	2.04%	3.42%	2.33%	3.04%

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.